Most Recent Articles by Sheila Jacobs
The use of urate-lowering therapy in patients with gout had neither beneficial nor adverse effects on long-term fracture risk.
High rates of false-positive results on the tuberculin skin test have been reported among patients treated with methotrexate.
Researchers sought to compare baseline characteristics between patients with PsA who achieved and did not achieve minimal disease activity with biologic therapy.
Results of the MAINRITSAN2 trial show that ANCA-associated vasculitides relapse rates did not differ significantly among patients treated with individually tailored vs fixed-schedule rituximab infusion regimens.
Ethnicity and hypertension have an association with incident gout that is not fully explained by differences in serum urate.
More Articles by Sheila Jacobs
Rheumatology Advisor Articles
- Alternative Measurement of Psoriasis Severity Effective in CZP-Treated Psoriatic Arthritis
- Incident Gout Risk, Serum Urate, and Comorbidities: What Are the Links?
- Addressing Psychiatric Comorbidities in Inflammatory Rheumatic Diseases
- Clinician Roundtable: Improving Quality of Life in Systemic Lupus Erythematosus
- Incidence of Clinically Significant GI Events in NSAID-Treated Arthritis
- EULAR Releases Recommendations for Pain Management in OA, Inflammatory Arthritis
- Risk of Developing Herpes Zoster Increased in Rheumatoid Arthritis
- Supervised, Intense Exercise Improves Physical Fitness in Older Adults With RA
- Risks Associated With Co-Administration of Aspirin and Other NSAIDs
- The Dorsal 4-Finger Technique: A New Method to Examine Joints in Rheumatoid Arthritis
- Gout, Urate-Lowering Therapy Not Associated With Risk for Fragility Fracture
- Does Exposure to Passive Smoke Increase Rheumatoid Arthritis Risk?
- Pegloticase Retreatment Effective for Gout After Gap in Therapy
- Tofacitinib Reduces MRI Inflammation, May Improve Outcomes in Ankylosing Spondylitis
- Associations Between Site-Specific BMD, Anthropometric, Glucose Homeostasis Traits